FDA Picks Nine Drugs for Fast-Track Reviews in New Program

The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump administration’s stated policy priorities.